MegaTran 2.0, plasmid DNA transfection reagent (0.5 mL)
CAT#: TT210002
MegaTran 2.0, plasmid DNA transfection reagent (0.5 mL), 330 rxns for 24-well plate
Learn More
TT210002 is a replacement of TT200002.
                
                
            CNY 1430.00
货期*
                        现货
                    规格
                        | Cited in 7 publications. | 
Specifications
| Product Data | |
| Description | MegaTran 2.0, plasmid DNA transfection reagent (0.5 mL), 330 rxns for 24-well plate | 
| Features | » Superior transfection efficiency » Broad cell spectrum » Competitive pricing | 
Citations (7)
| The use of this Others has been cited in the following citations: | 
|---|
| Tumor specificity of WNT ligands and receptors reveals universal squamous cell carcinoma oncogenes
                                                ,null,
                                                BMC Cancer
                                                ,PubMed ID 35850748 | 
| Evaluation of the putative lymphoma-associated point mutation D427H in the STAT3 transcription factor
                                                ,null,
                                                BMC Molecular and Cell Biology
                                                ,PubMed ID 35752777 | 
| Novel Pathogenetic Variants in PTHLH and TRPS1 Genes Causing Syndromic Brachydactyly
                                                ,null,
                                                Journal of Bone and Mineral Research
                                                ,PubMed ID 34897794 | 
| N ‐Acylethanolamine acid amidase (NAAA) is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth
                                                ,null,
                                                British Journal of Pharmacology
                                                ,PubMed ID 34791641 | 
| A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis
                                                ,Chen, Y;Zhou, Y;Han, F;Zhao, Y;Tu, M;Wang, Y;Huang, C;Fan, S;Chen, P;Yao, X;Guan, L;Yu, AM;Gonzalez, FJ;Huang, M;Bi, H;,
                                                Theranostics
                                                ,PubMed ID 32641987
                                                [MegaTran 2.0] | 
| BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis
                                                ,Barton, M;Santucci-Pereira, J;Vaccaro, OG;Nguyen, T;Su, Y;Russo, J;,
                                                BMC Cancer
                                                ,PubMed ID 31646972
                                                [MegaTran 2.0] | 
| Transcriptional factor Nrf2 is essential for aggresome formation during proteasome inhibition
                                                ,Qin, S;Jiang, C;Gao, J;,
                                                biom rep
                                                ,PubMed ID 31798869
                                                [MegaTran 2.0] | 
Documents
                         Customer
                                Reviews 
                    
                    
                                Loading...
                            
                        
 
                         
        